Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

A lawyer with a Ph.D. in biology, Matthew Hegreness provides regulatory counsel to the firm’s food, dietary supplement, and pharmaceutical clients as they develop new products, ingredients, treatments, and claims. He also advises on regulatory issues that arise in legal proceedings and corporate transactions. When advocating for clients before the U.S. FDA and other agencies, Dr. Hegreness draws on his skills in law and science to reach the range of relevant professionals—lawyers as well as scientists and medical doctors.

  • Advises companies on the labeling and advertising of food, dietary supplements, and medical products.
  • Counsels businesses on the development and approval of drugs and biologics, including on exclusivity strategies.
  • Advises pharmaceutical and dietary supplement trade associations.
  • Defends clients in FTC investigations related to the advertising of food and dietary supplements.
  • Advises on regulatory risks associated with the purchase of food, biotech, and pharmaceutical companies.

Previous Experience

  • Member of the Yale Supreme Court Advocacy Clinic (2011-2012).
  • Scientific researcher at Harvard University in the laboratories of systems biologist Roy Kishony and population geneticist Daniel Hartl (2003-2008).